
    
      To evaluate the single-dose pharmacokinetic (PK) profiles of ceftaroline and avibactam
      following intravenous (IV) administration of ceftaroline fosamil/avibactam ("CXL") in adults
      with augmented renal clearance (ARC).
    
  